GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Second Sight Medical Products Inc (NAS:EYESW) » Definitions » Debt-to-Revenue

EYESW (Second Sight Medical Products) Debt-to-Revenue : N/A (As of Jun. 2022)


View and export this data going back to 2017. Start your Free Trial

What is Second Sight Medical Products Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Second Sight Medical Products's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2022 was $0.15 Mil. Second Sight Medical Products's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2022 was $0.00 Mil. Second Sight Medical Products's annualized Revenue for the quarter that ended in Jun. 2022 was $0.00 Mil.


Second Sight Medical Products Debt-to-Revenue Historical Data

The historical data trend for Second Sight Medical Products's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Second Sight Medical Products Debt-to-Revenue Chart

Second Sight Medical Products Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Debt-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 0.77 N/A N/A

Second Sight Medical Products Quarterly Data
Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only N/A N/A N/A N/A N/A

Competitive Comparison of Second Sight Medical Products's Debt-to-Revenue

For the Medical Devices subindustry, Second Sight Medical Products's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Second Sight Medical Products's Debt-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Second Sight Medical Products's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Second Sight Medical Products's Debt-to-Revenue falls into.



Second Sight Medical Products Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Second Sight Medical Products's Debt-to-Revenue for the fiscal year that ended in Dec. 2021 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(0.185 + 0.052) / N/A
=N/A

Second Sight Medical Products's annualized Debt-to-Revenue for the quarter that ended in Jun. 2022 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Jun. 2022) Revenue data.


Second Sight Medical Products Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Second Sight Medical Products's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Second Sight Medical Products Business Description

Traded in Other Exchanges
N/A
Address
13170 Telfair Avenue, Sylmar, CA, USA, 91342
Second Sight Medical Products Inc develops, manufactures, and markets implantable prosthetic devices to create an artificial form of useful vision for blind individuals. The company's product Argus II System treats outer retinal degenerations, such as Retinitis Pigmentosa, often referred to as RP. The company generates revenue from the sale of its Argus II retinal prosthesis systems, which include the implant and external components. Geographically, the company operates in the United States, Italy, China, and of which key revenue is derived from the United States.